Tumor Prostate-Specific Antigen Density Can Predict Tumor Aggressiveness and Heterogeneity in Prostate Cancer [0.03%]
肿瘤前列腺特异性抗原密度可以预测前列腺癌的肿瘤侵略性和异质性
Tao Yang,Xin&#x;an Wang,Yalong Deng et al.
Tao Yang et al.
Background: Prostate cancer is a highly heterogeneous disease, this study assessed the association between tumor prostate-specific antigen density (TPSAD) and tumor heterogeneity in prostate cancer. ...
Personalizing BPH Management: Bladder Stone Removal Alone vs. With Concomitant Laser Enucleation-A Multicenter Perspective With Patient Reported Outcomes and Decisional Regret Analysis [0.03%]
个性化治疗BPH：单独取石与同时进行激光剥除的比较——基于多中心患者报告结局及决策后悔分析的观点
Ziv Savin,Tomer Mendelson,Linda Dayan Rahmani et al.
Ziv Savin et al.
Introduction: The necessity of routinely combining bladder stone removal with surgical treatment for BPH remains debated. We compared the efficacy and safety of bladder stone removal with and without concomitant outlet su...
In the Era of mpMRI and PSMA PET/CT: Does Digital Rectal Examination Still Matter? [0.03%]
在mpMRI和PSMA PET/CT的时代：数字直肠检查还重要吗？
Anil Eker,Fatih Diler,Selda Yilmaz Tatar et al.
Anil Eker et al.
Background: With the increasing integration of multiparametric MRI (mpMRI) and 68Ga-PSMA PET/CT into the diagnostic and staging algorithms of prostate cancer (PCa), digital rectal examination (DRE)-a once foundational and...
[18F] PSMA PET-CT and [18F] Choline PET-CT in the Diagnosis of High-Risk Localized Prostate Cancer: Comparation of Both Tests [0.03%]
[18F] PSMA-PET/CT和[18F]胆碱PET/CT在高危局限性前列腺癌诊断中的比较研究
M A Tárraga-Honrubia,A S Salinas-Sánchez,S Navarro-Jiménez et al.
M A Tárraga-Honrubia et al.
Background: To compare choline PET-CT and PSMA PET-CT in a cohort of patients with high-risk localized prostate cancer, assessing the diagnostic capacity of both tests. whose therapeutic approach could be modified based o...
Defining Favorable Prognosis in Bone Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors [0.03%]
定义接受雄激素受体信号抑制剂治疗的骨转移性荷尔蒙敏感性前列腺癌的良好预后标准
Dai Koguchi,Hideyasu Tsumura,Ken-Ichi Tabata et al.
Dai Koguchi et al.
Background: This study aimed to identify patients who would benefit from androgen receptor signaling inhibitor (ARSI) therapy in metastatic hormone-sensitive prostate cancer (mHSPC) with bone metastasis (BM). Therefore, w...
Utilization of Real-World Evidence in the Evaluation of Post-Surgical Incontinence in Men Undergoing Surgical Treatment for Benign Prostatic Hyperplasia [0.03%]
真实世界证据在外科治疗良性前列腺增生的男性术后尿失禁评估中的应用研究
Zizwa Mwafulirwa,Kathryn Goodrich,Ariel Roane et al.
Zizwa Mwafulirwa et al.
Introduction and objectives: Post-surgical urinary incontinence (PSI) can occur after benign prostatic hyperplasia (BPH) surgery. Estimating incontinence risks across modalities largely relies upon reports from single sur...
Metabolomic Insights Into Saliva as a Non-Invasive Surrogate for Serum to Enable Community-Based Biomarker Investigation [0.03%]
代谢组学视角下的唾液研究：作为非侵入性血清代理进行社区生物标志物调查的新见解
Alireza Abdshah,Mohammad Alyamani,Robert A Burgess et al.
Alireza Abdshah et al.
Introduction: Using serum metabolomics in Community-Based Participatory Research (CBPR) with underserved populations presents challenges due to the invasive nature of venipuncture, which limits longitudinal sample collect...
A Dual-Threshold Strategy Enables Reliable Biopsy-Free Diagnosis of High-Risk Prostate Cancer [0.03%]
一种双重阈值策略可实现高危前列腺癌无活检的可靠诊断
Yong Liang,Zhiqiang Chen,Jingliang Zhang et al.
Yong Liang et al.
Background: Several studies have suggested that biopsy-free radical prostatectomy reduces burdens for selected prostate cancer (PCa) patients pre-screened by clinical indicators and PSMA-PET/CT. However, the absence of pr...
Smoking Behavior Is Associated With an Altered Immune Landscape in Prostate Cancer: Implications for Patient Outcomes [0.03%]
吸烟行为与前列腺癌免疫微环境的改变及临床预后的关系
Amod Sharma,Sarabjeet Kour Sudan,Mohammad Aslam Khan et al.
Amod Sharma et al.
Background: Smoking is a modifiable risk factor for prostate cancer (PCa) diagnosis, recurrence, and mortality. While the mutagenic effects of tobacco are well-documented, the immunological consequences of smoking within ...
Corticosteroid Use and Risk of Adverse Events in Metastatic Hormone-Sensitive Prostate Cancer [0.03%]
皮质类固醇使用与转移性激素敏感性前列腺癌不良事件风险的关系
Umang Swami,Qiujun Shao,Tamuno Alfred et al.
Umang Swami et al.
Background: Among the approved therapies for metastatic hormone-sensitive prostate cancer (mHSPC), abiraterone and docetaxel are administered concomitantly with corticosteroids. This study evaluated the association betwee...